PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 26,504 shares of the business’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $46.50, for a total transaction of $1,232,436.00. Following the completion of the transaction, the chief executive officer owned 54,121,535 shares of the company’s stock, valued at $2,516,651,377.50. The trade was a 0.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Wednesday, November 4th, Jason Murray sold 167,434 shares of PACS Group stock. The stock was sold at an average price of $50.24, for a total transaction of $8,411,884.16.
- On Monday, November 2nd, Jason Murray sold 31,358 shares of PACS Group stock. The stock was sold at an average price of $46.02, for a total transaction of $1,443,095.16.
- On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The shares were sold at an average price of $50.05, for a total transaction of $95,295.20.
- On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The shares were sold at an average price of $50.10, for a total transaction of $345,639.90.
- On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total transaction of $3,349,366.20.
- On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total transaction of $651,244.80.
- On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total value of $314,768.20.
- On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total value of $1,785,779.05.
- On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total value of $77,063.40.
- On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total value of $402,875.82.
PACS Group Trading Up 8.5%
Shares of PACS opened at $50.63 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $51.68. The firm has a market cap of $8.01 billion, a price-to-earnings ratio of 21.32, a PEG ratio of 1.46 and a beta of -0.14. The business’s fifty day moving average is $44.42 and its 200-day moving average is $39.91.
PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.46 billion. PACS Group had a return on equity of 33.39% and a net margin of 4.87%. Equities analysts anticipate that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.
Institutional Investors Weigh In On PACS Group
Several hedge funds have recently modified their holdings of the company. Financial Management Professionals Inc. grew its position in PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after acquiring an additional 235 shares during the last quarter. GK Wealth Management LLC acquired a new position in PACS Group in the 3rd quarter worth about $41,000. USA Financial Formulas acquired a new position in PACS Group in the 3rd quarter worth about $46,000. KBC Group NV bought a new position in PACS Group in the first quarter valued at about $42,000. Finally, Western Wealth Management LLC bought a new position in PACS Group in the first quarter valued at about $48,000.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Truist Financial set a $62.00 price target on shares of PACS Group in a research note on Wednesday, September 2nd. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Royal Bank Of Canada upped their price objective on shares of PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Finally, Oppenheimer increased their price objective on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $58.80.
Get Our Latest Analysis on PACS
Key Stories Impacting PACS Group
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
- Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
See Also
- Five stocks we like better than PACS Group
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
